Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02443779 · ClinicalTrials.gov registry record

Relationship Between Symptoms, Retinal Morphology, and the Nigrostriatal Dopamine System in Parkinson's Disease

A clinical trial of Parkinson's Disease, sponsored by Thomas Jefferson University.

Completed
Registry status
7
Enrollment target
1
Study location

NCT02443779 is a study of Parkinson's Disease that has completed, run by Thomas Jefferson University. The registered enrollment target is 7 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02443779, a study of Parkinson's Disease, has completed, sponsored by Thomas Jefferson University.

COMPLETED
Registry status
7 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine if a correlation exists between findings from brain imaging studies of the status of the dopamine system in the brain using DaTscan and SPECT imaging, clinical symptoms of Parkinson's disease, and changes in the structure of the retina as detected by optical coherence tomography (OCT) in recently diagnosed and more advanced Parkinson's disease patients.

Conditions Studied

Study Locations (1)

Pennsylvania

  • Thomas Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2015-12
Est. Completion 2018-07

Sponsor

Thomas Jefferson University

292 total trials

What the Registry Record Tells You About NCT02443779

The ClinicalTrials.gov registry entry for NCT02443779 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (99% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.

NCT02443779 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02443779 about?

NCT02443779 is a clinical study titled "Relationship Between Symptoms, Retinal Morphology, and the Nigrostriatal Dopamine System in Parkinson's Disease". The purpose of this study is to examine if a correlation exists between findings from brain imaging studies of the status of the dopamine system in the brain using DaTscan and SPECT imaging, clinical symptoms of Parkinson's disease, and changes in the structure of the retina as detected by optical c...

What is the current status of trial NCT02443779?

This trial is currently completed. The enrollment target is 7 participants. The study started on 2015-12. Estimated completion is 2018-07.

What conditions does trial NCT02443779 study?

This clinical trial studies the following conditions: Parkinson's Disease.

Who is sponsoring clinical trial NCT02443779?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02443779 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.